HomeAI · summaries
Storia in 6 fonti
FDA Approves Eli Lilly’s GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
FDA Approves Eli Lilly’s Weight Loss Pill Foundayo—Fewer Food And Drink Restrictions
Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.
- ·
cnbc.com
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
